Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Premium

Register

Sign In

EUR/USD

1.2288

-0.0056

-0.45%

GBP/USD

1.4003

-0.0079

-0.56%

USD/JPY

107.65

0.2200

0.20%

USD/CHF

0.9750

0.0033

0.34%

EUR/GBP

0.8774

0.0009

0.10%

USD/CAD

1.2765

0.0100

0.79%

NZD/USD

0.7208

-0.0057

-0.78%

EUR/JPY

132.29

-0.3180

-0.24%

EUR/CHF

1.1980

-0.0014

-0.12%

Argos Therapeutics Inc.

NASDAQ: ARGSHealthcare / Biotechnology / USA
0.29-0.05-14.71%Vol 3 014 3931Y Perf -96.95%
Apr 20th, 2018 15:59
BID0.30 ASK0.33
Open0.34 Previous Close0.34
Pre-Market0.33 After-Trading-
 -0.01 -2.94%  - -%
Target Price
0.75 
Analyst Rating
— 0.00
Potencial %
158.62 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)2 
Earnings Rating
Buy
Price Range Ratio 52wk %
0.18 
Earnings Date
9th May 2018

Today's Price Range

0.270.36

 

52wk Range

0.2711.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-75.42%
3 Months
-86.64%
6 Months
81.25%
1 Year
-96.95%
3 Years
-96.62%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
ARGS0.29-0.0500-14.71
AAPL165.72-7.0800-4.10
GOOG1 072.96-14.7400-1.36
MSFT95.00-1.1100-1.15
XOM79.00-0.4200-0.53
WFC52.561.02001.98
JNJ126.66-0.8900-0.70
FB166.28-1.8200-1.08
GE14.540.55003.93
JPM111.47-0.2500-0.22
...

TickerPriceChg.%52 Week High
RF18.894.0820.21
XRX31.543.9937.42
GE14.543.9330.38
HRB27.102.9231.80
ETFC60.482.8061.80
SCHW54.992.4458.11
SIG38.652.1777.94
UAL71.752.1683.04
WFC52.561.9866.31
RE246.991.91277.17
M29.961.8731.04
CTL17.611.6727.61
HON150.571.65165.13
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.60
Current Ratio 1.80
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -30.00
Leverage Ratio -1.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-23 979.50
EBITDA Margin-23 727.60
Pre-tax Profit Margin-5 083.00
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.88
PS Ratios 4.63
Price to Cash Flow -
Price to Free Cash Flow -0.40
Cash Flow Per Share -11.74
Price to Tangible Book-0.90
Book Value per Share-1.17
Enterprise Value (in ths.)12 573
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)243.40
ROE last 12 Months 2 648.33
Return on Assets (5Y Avg) -86.94
ROA last 12 Months -68.79
Return on Capital (5Y Avg) -
ROC last 12 Months -186.76
Return on invested Capital Q -
Return on invested Capital Y-32.59
Assets Turnover0.00
Receivables Turnover3.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1 794
Revenue per Share 0.23
Revenue Growth 3 Years 17.54
Revenue Growth 5 Years -31.92
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017--1.05-
Q03 2017--0.10-
Q02 2017-0.13-0.21-61.54
Q01 2017--0.58-
Q03 2016-0.32-0.320.00
Q02 2016-0.40-0.48-20.00
Q01 2016-0.56-0.57-1.79
Q04 2015-0.86-0.842.33
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.15-7.14Negative
12/2017 QR-0.150.00-
12/2017 FY-1.08-22.73Negative
12/2018 FY-0.48-9.09Negative
Next Report Date9th May 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume3 014 393
Shares Outstanding (in ths.)7 910
Trades Count2 490
Dollar Volume833 504
Avg. Volume886 622
Avg. Weekly Volume2 619 492
Avg. Monthly Volume1 101 993
Avg. Quarterly Volume996 272

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

80%20%

Bearish Bullish

81%19%

Bearish Bullish

73%27%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
2 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Hold
3.00

There are no comments yet.

News

x